| 注册
首页|期刊导航|癌变·畸变·突变|免疫杀手细胞的体外扩增方法及其对肝癌细胞BEL-7402的杀伤作用

免疫杀手细胞的体外扩增方法及其对肝癌细胞BEL-7402的杀伤作用

王生育 罗芳洪 倪二茹 吕海燕 支黎明 颜江华 张顺浪

癌变·畸变·突变2012,Vol.24Issue(2):121-124,128,5.
癌变·畸变·突变2012,Vol.24Issue(2):121-124,128,5.DOI:10.3969/j.issn.1004-616x.2012.02.009

免疫杀手细胞的体外扩增方法及其对肝癌细胞BEL-7402的杀伤作用

Evaluation of a modified culture method for immune-killer cells and therapeutic efficiency on hepatocarcinoma cell line BEL-7402

王生育 1罗芳洪 1倪二茹 1吕海燕 1支黎明 1颜江华 1张顺浪2

作者信息

  • 1. 厦门大学医学院抗癌研究中心,福建厦门361005
  • 2. 厦门长春堂科技有限公司,福建厦门361005
  • 折叠

摘要

Abstract

OBJECTIVE:To evaluate the modified culture method and the therapeutic efficiency of immune-killer cells (IKCs) on a hepatocarcinoma cell line BEL-7402. METHODS: IKCs were induced and amplified from PBMC cells in a modified NK culture method. The immunophenotype changes were analyzed by flow cytometry. The proliferation of the cells were evaluated by Trypan-blue staining. The killing activities on BEL-7402 cell line were detected by Alamar Blue staining and their effect on BEL-7402 tumor in the nude mice model were examined by monitoring tumor growth. RESULTS: The IKCs cultured for 14 days- multiplied approximately 300 times. Cell subsets of CD3+CD56+, CD3-CD56+ and CD8+ were the major components. Both ratios of CD3+CD56+ and CD3-CD56+ were higher than 85%, while the ratio of CD8+ was higher than 77%. At the effector-target ratio of 25: 1 and 100: 1, the killing activity against BEL-7402 cells of IKCs was 66.5% (P< 0.01) and 97.8% (P< 0.01), respectively. Treatment with IKCs on BEL-7402 tumor in nude mice showed a noticeable higher therapeutic effect than that of control, with an inhibition ratio on tumor growth of 69% (P< 0.01). CONCLUSION: The modified culture method for IKCs was practicable and effective. The research might provide experimental basis for clinical immunotherapy of IKCs on hepatocarcinoma.

关键词

免疫杀手细胞/肝癌/杀伤

Key words

immune-killer cells/ hepatocarcinoma/ killing activity

分类

医药卫生

引用本文复制引用

王生育,罗芳洪,倪二茹,吕海燕,支黎明,颜江华,张顺浪..免疫杀手细胞的体外扩增方法及其对肝癌细胞BEL-7402的杀伤作用[J].癌变·畸变·突变,2012,24(2):121-124,128,5.

基金项目

厦门长春堂科技有限公司体细胞研究与应用项目(XDHT2007001C) (XDHT2007001C)

福建省科技专项(2009R10020-1) (2009R10020-1)

癌变·畸变·突变

OACSCDCSTPCD

1004-616X

访问量0
|
下载量0
段落导航相关论文